Uniphar

FY2023 results reflect strong organic gross profit growth

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 280c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

DAVY VIEW

Uniphar’s FY2023 results reflect strong organic growth in gross profits of 5.6% year-on-year (yoy). Adjusted EBITDA expanded 18% yoy. Higher interest costs and depreciation charges held back bottom-line earnings. The outlook is positive, and we are maintaining our forecasts.

Download full report with analyst certification and important disclosures

Feb 27 2024, 07:10 GMT

Download